PubRank

E L Morgan

Author PubWeight™ 55.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol 1983 1.41
2 Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 1994 1.28
3 Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. J Immunol 1983 1.22
4 Trabecular bone mineral density in idiopathic scoliosis. J Pediatr Orthop 1987 1.19
5 C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol 1990 1.16
6 The requirement for adherent cells in the Fc fragment-induced proliferative response of murine spleen cells. J Exp Med 1979 1.15
7 Regulation of Fc fragment-induced murine spleen cell proliferation. J Exp Med 1980 1.12
8 Polyclonal activation of human B lymphocytes by Fc fragments. I. Characterization of the cellular requirements for Fc fragment-mediated polyclonal antibody secretion by human peripheral blood B lymphocytes. J Exp Med 1981 1.07
9 Association of bone mineral density and pediatric fractures. J Pediatr Orthop 1987 1.07
10 Polyclonal activation of murine B lymphocytes by Fc fragments. I. The requirement for two signals in the generation of the polyclonal antibody response induced by Fc fragments. J Immunol 1980 1.04
11 Regulation of the immune response. I. The potentiation of in vivo and in vitro immune responses by Fc fragments. J Exp Med 1980 1.02
12 Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol 1983 1.02
13 Enhancement of T lymphocyte functions by Fc fragments of immunoglobulins. I. Augmentation of allogeneic mixed lymphocyte culture reactions requires I-A- or I-B-subregion differences between effector and stimulator cell populations. J Exp Med 1981 1.01
14 The requirement for the Fc portion of antibody in antigen-antibody complex-mediated suppression. J Immunol 1978 1.01
15 Fc fragment activation of T lymphocytes. I. Fc fragments trigger Lyt 1+23- T lymphocytes to release a helper T cell-replacing activity. J Immunol 1981 1.01
16 B lymphocyte differentiation in the CBA/N mouse: a delay in maturation rather than a total arrest. J Immunol 1980 1.00
17 Anaphylatoxin-mediated regulation of human and murine immune responses. Fed Proc 1984 1.00
18 C3d-K, a kallikrein cleavage fragment of iC3b is a potent inhibitor of cellular proliferation. J Immunol 1984 0.97
19 Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat. J Pharmacol Exp Ther 1984 0.96
20 Biological activities residing in the Fc region of immunoglobulin. Adv Immunol 1987 0.96
21 Modulation of the induction and circumvention of immunological tolerance to human gamma-globulin by interleukin 1. J Immunol 1987 0.95
22 Polyclonal activation of murine B lymphocytes by immune complexes. J Immunol 1983 0.94
23 Aggregated human gamma-globulin-induced proliferation and polyclonal activation of murine B lymphocytes. J Immunol 1980 0.94
24 Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. J Immunol 1998 0.93
25 Polyclonal activation of murine B lymphocytes by Fe fragments. II. Replacement of T cells by a soluble helper T cell-replacing factor (TRF). J Immunol 1980 0.93
26 Regulation of the immune response: III. The role of macrophages in the potentiation of the immune response by Fc fragments. J Immunol 1981 0.92
27 Regulation of antibody responses by rheumatoid factor. I. Polyclonal activation of human B cells by rheumatoid factor-containing preparations from seropositive plasma. J Immunol 1985 0.91
28 Roentgenographic measurement of pedicle screw penetration. Clin Orthop Relat Res 1989 0.91
29 Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin. J Immunol 1997 0.91
30 Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses. J Exp Med 1982 0.90
31 Modulation of the immune response by anaphylatoxins. Complement 1986 0.89
32 Regulation of the immune response. II. Characterization of the cell population(s) involved in the Fc fragment-induced adjuvant effect. J Immunol 1980 0.88
33 Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells. Fed Proc 1982 0.88
34 Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. J Immunol 1995 0.88
35 Isolation and identification of a biologically active peptide derived from the CH3 domain of human IgG1. Proc Natl Acad Sci U S A 1982 0.86
36 The role of antigen-antibody complexes in mediating immunologic unresponsiveness in the chicken. J Immunol 1977 0.86
37 Lymphocyte phenotype and function in pseudolymphoma associated with Sjögren's syndrome. J Clin Invest 1983 0.85
38 Mechanisms of leukocyte regulation by complement-derived factors. Contemp Top Immunobiol 1984 0.84
39 Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptor. J Immunol 1997 0.83
40 Regulation of B lymphocyte activation by the Fc portion of immunoglobulin. J Supramol Struct 1980 0.83
41 Enhancement of T. lymphocyte functions by Fc fragments of immunoglobulin. II. Augmentation of the cell-mediated lympholysis response occurs through an Lyt-1+2- helper T cell. J Immunol 1981 0.82
42 Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens. J Immunol 1985 0.81
43 Suppression of humoral immune responses by synthetic C3a peptides. J Immunol 1983 0.81
44 Potentiation of specific human in vitro immune responses by the Fc portion of human immunoglobulin. Clin Exp Immunol 1983 0.81
45 Activation of T lymphocytes by the Fc portion of immunoglobulin. J Supramol Struct 1980 0.81
46 Synthetic Fc peptide-mediated regulation of the immune response. II. Analysis of secreted immunoglobulin classes, accessory cell contribution, and lymphocyte proliferation in p23-stimulated spleen cell cultures. J Immunol 1985 0.80
47 Trabecular bone density and menstrual function in women runners. Am J Sports Med 1987 0.79
48 Comparison of the binding of radiolabelled human IgG and Fc fragments to murine spleen cells. Scand J Immunol 1979 0.79
49 The role of prostaglandins in C3a-mediated suppression of human in vitro polyclonal antibody responses. Clin Immunol Immunopathol 1987 0.78
50 Interactions of epinephrine, norepinephrine, dopamine and their corresponding alpha-methyl-substituted derivatives with alpha and beta adrenoceptors in the pithed rat. J Pharmacol Exp Ther 1984 0.78
51 Fibronectin augments anti-CD3-mediated IL-2 receptor (CD25) expression on human peripheral blood lymphocytes. Cell Immunol 1991 0.78
52 Human C3a-mediated suppression of the immune response. I. Suppression of murine in vitro antibody responses occurs through the generation of nonspecific Lyt-2+ suppressor T cell. J Immunol 1985 0.78
53 Lymphocyte activation by the Fc region of immunoglobulins. Immunol Invest 1986 0.78
54 The immune response in aged C57BL/6 mice. II. Characterization and reversal of a defect in the ability of aged spleen cells to respond to the adjuvant properties of Fc fragments. J Immunol 1982 0.78
55 Interaction of the novel inotropic agent, ASL-7022, with alpha and beta adrenoceptors in the cardiovascular system of the pithed rat: comparison with dobutamine and dopamine. J Pharmacol Exp Ther 1984 0.78
56 Role of Fc receptors in lymphocyte activation: deficiency in T- and B-lymphocytes from aged animals. Mol Immunol 1982 0.77
57 Lymphocyte stimulation with Fc fragments. II. Requirement for mature B lymphocytes. Cell Immunol 1980 0.77
58 The immune response in aged C57BL/6 mice. I. Assessment of lesions in the B-cell and T-cell compartments of aged mice utilizing the Fc fragment-mediated polyclonal antibody response. Cell Immunol 1981 0.77
59 Bioactive complement fragments in immunoregulation. Immunol Lett 1985 0.76
60 Synthetic Fc peptide-mediated regulation of the immune response. I. Characterization of the immunomodulating properties of a synthetic 23-amino acid peptide derived from the sequence of the CH3 domain of human IgG1. J Exp Med 1983 0.76
61 Immunologic tolerance in the chicken. I. Isolation of two suppressive fractions from serum of chickens tolerant to bovine serum albumin. J Immunol 1978 0.75
62 Lymphocyte activation by the Fc region of immunoglobulin. I. Role of prostaglandins in the down regulation of Fc fragment-induced polyclonal antibody production. J Immunol 1985 0.75
63 Human C3a-mediated suppression of the immune response. II. Suppression of human in vitro polyclonal antibody responses occurs through the generation of nonspecific OKT8+ suppressor T cells. Clin Immunol Immunopathol 1985 0.75
64 The role of the adherent cell in antigen-antibody complex induced immune unresponsiveness. Adv Exp Med Biol 1977 0.75
65 Immunological tolerance in the chicken. III. Partial physiochemical characterization of two suppressive fractions from serum of chickens tolerant to bovine serum albumin. Scand J Immunol 1982 0.75
66 Regulation of the in vitro secondary antibody response. II. Antigen-induced murine splenic T cell proliferation. J Immunol 1981 0.75
67 Effect of acute gamma radiation on wild opossum, gray fox, raccoon and bobcat. Health Phys 1965 0.75
68 Interaction of the enantiomers of 3-0-methyldobutamine, a metabolite of dobutamine, with alpha- and beta-adrenoreceptors in the cardiovascular system of the pithed rat. J Auton Pharmacol 1984 0.75
69 Induction of human B cell differentiation by Fc region activators. I. Identification of an active tetrapeptide. Clin Immunol Immunopathol 1989 0.75
70 Potentiation of the rat delayed-type hypersensitivity reaction by the Fc portion of human IgG1. Cell Immunol 1984 0.75
71 Antagonistic regulatory properties of the Fc region of immunoglobulin. Immunopharmacology 1986 0.75
72 Identification of a lymphocyte-activating pentapeptide sequence in the Fc region of human IgG1. J Immunol 1987 0.75
73 Bifunctional lymphocyte regulation by human Fc gamma fragments and a synthetic peptide, p23, derived from the Fc region. Immunol Lett 1985 0.75
74 Polyclonal activation of murine B lymphocytes by Fc fragments. III. Characterization of the defect in the ability of the C3H/HeJ mouse to respond to Fc fragments. J Immunol 1980 0.75
75 Binding and processing of immunostimulatory Fc gamma 1 fragments by the murine macrophage cell line P388D1. Cell Immunol 1985 0.75
76 Effects of dietary iodine on the thyroidal uptake and elimination of 131-iodine in Coturnix and Bobwhite quail. Poult Sci 1970 0.75
77 Immunologic tolerance in the chicken. II. Isolation and characterization of a soluble factor from a macrophage-like cell from chickens tolerant to bovine serum albumin. Cell Immunol 1979 0.75
78 The inability of CBA/N mice to proliferate in response to Fc fragments from human immunoglobulin is an age-related defect. Cell Immunol 1980 0.75